Search results
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 8 hours agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
U.S. to start offering COVID-19 vaccine booster doses in September
AOL· 4 days agoThe White House is prepared to offer a third booster shot starting on that date to all Americans who...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 1 day agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 1 day agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 1 day agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 1 day agoThis was compared to 67.2% efficacy for RSV and 78.8% efficacy for severe RSV in adults who had...
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 6 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez ...
US opens COVID vaccine to little kids, shots begin next week
AOL· 3 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for...
Morningstar· 6 days agoPfizer Inc. (NYSE: PFE)announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with ...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 2 days agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed up with the participants for one year, during which ...